Lu Li
Stock Analyst at Bank of America Securities
(2.85)
# 2,743
Out of 5,082 analysts
40
Total ratings
64.7%
Success rate
6.9%
Average return
Main Sectors:
Stocks Rated by Lu Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Reiterated: Buy | $255 → $270 | $231.50 | +16.63% | 3 | Oct 22, 2026 | |
| MYGN Myriad Genetics | Reiterated: Sell | $6 → $3.2 | $4.35 | -26.44% | 8 | Oct 21, 2026 | |
| LH Labcorp Holdings | Maintained: Buy | $360 | $325.07 | +10.75% | 1 | Oct 16, 2026 | |
| AVTR Avantor | Reiterated: Hold | $17 | $16.09 | +5.66% | 1 | Oct 9, 2026 | |
| CAI Caris Life Sciences | Reiterated: Buy | $35 | $31.76 | +10.20% | 1 | Oct 9, 2026 | |
| GH Guardant Health | Reiterated: Buy | $200 | $165.88 | +20.57% | 1 | Oct 9, 2026 | |
| ICLR ICON Public Limited Company | Upgraded: Hold | n/a | $175.13 | - | 1 | Oct 9, 2026 | |
| ILMN Illumina | Reiterated: Sell | $168 | $267.93 | -37.30% | 1 | Oct 9, 2026 | |
| QGEN Qiagen | Reiterated: Buy | $50 | $46.17 | +8.30% | 1 | Oct 9, 2026 | |
| RVTY Revvity | Reiterated: Hold | $165 | $154.71 | +6.65% | 1 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $75 | $71.13 | +5.44% | 1 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $17.25 | - | 2 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $17 → $12 | $13.91 | -13.73% | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $52 | $44.39 | +17.14% | 6 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $330 → $375 | $444.15 | -15.57% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $22 | $21.34 | +3.09% | 3 | Mar 2, 2026 |
Danaher
Oct 22, 2026
Reiterated: Buy
Price Target: $255 → $270
Current: $231.50
Upside: +16.63%
Myriad Genetics
Oct 21, 2026
Reiterated: Sell
Price Target: $6 → $3.2
Current: $4.35
Upside: -26.44%
Labcorp Holdings
Oct 16, 2026
Maintained: Buy
Price Target: $360
Current: $325.07
Upside: +10.75%
Avantor
Oct 9, 2026
Reiterated: Hold
Price Target: $17
Current: $16.09
Upside: +5.66%
Caris Life Sciences
Oct 9, 2026
Reiterated: Buy
Price Target: $35
Current: $31.76
Upside: +10.20%
Guardant Health
Oct 9, 2026
Reiterated: Buy
Price Target: $200
Current: $165.88
Upside: +20.57%
ICON Public Limited Company
Oct 9, 2026
Upgraded: Hold
Price Target: n/a
Current: $175.13
Upside: -
Illumina
Oct 9, 2026
Reiterated: Sell
Price Target: $168
Current: $267.93
Upside: -37.30%
Qiagen
Oct 9, 2026
Reiterated: Buy
Price Target: $50
Current: $46.17
Upside: +8.30%
Revvity
Oct 9, 2026
Reiterated: Hold
Price Target: $165
Current: $154.71
Upside: +6.65%
Oct 9, 2026
Reiterated: Hold
Price Target: $75
Current: $71.13
Upside: +5.44%
Oct 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $17.25
Upside: -
May 7, 2026
Rated: Hold
Price Target: $17 → $12
Current: $13.91
Upside: -13.73%
May 6, 2026
Reiterated: Buy
Price Target: $48 → $52
Current: $44.39
Upside: +17.14%
May 6, 2026
Reiterated: Hold
Price Target: $330 → $375
Current: $444.15
Upside: -15.57%
Mar 2, 2026
Reiterated: Buy
Price Target: $35 → $22
Current: $21.34
Upside: +3.09%